Dose-dependent and duration-dependent analyses revealed a nonsignificant trend of lower incidence of acute pancreatitis in users treated with larger accumulative doses or longer durations.
← all excerpts
Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study.
1
—
—